Published in Arch Dermatol Res on January 01, 1984
Cell culture studies on neurofibromatosis (von Recklinghausen's disease). IV. Collagen synthesis. Arch Dermatol Res (1986) 0.75
Von Recklinghausen neurofibromatosis. N Engl J Med (1981) 7.69
A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem (1981) 4.19
S-100 protein in soft-tissue tumors derived from Schwann cells and melanocytes. Am J Pathol (1982) 2.31
Antibodies to distinct types of collagens and procollagens and their application in immunohistology. J Immunol Methods (1977) 1.82
Immunofluorescent localization of type IV collagen and laminin in human skin and its application in junctional zone pathology. Br J Dermatol (1982) 1.01
[Ultrastructure of neurofibromatosis]. Hautarzt (1972) 0.94
Cutaneous manifestations of neural crest disorders (neurocristopathies). Int J Dermatol (1977) 0.85
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol (1988) 16.45
The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science (1994) 3.07
A disease severity scale for systemic sclerosis: development and testing. J Rheumatol (1999) 2.85
Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve. Neuron (2001) 2.68
Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. J Cell Sci (1998) 2.60
Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J (1991) 2.23
Mortality ascertainment in the veteran population: alternatives to the National Death Index. Am J Epidemiol (1995) 2.14
Integrin alpha 2 beta 1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils. J Cell Biol (1991) 2.08
Impaired wound healing in embryonic and adult mice lacking vimentin. J Cell Sci (2000) 1.92
Biosynthesis of two subunits of type IV procollagen and of other basement membrane proteins by a human tumor cell line. Eur J Biochem (1980) 1.90
Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J Cell Biol (1995) 1.82
Inhibiting effect of procollagen peptides on collagen biosynthesis in fibroblast cultures. J Biol Chem (1979) 1.80
Integrin VLA-3: ultrastructural localization at cell-cell contact sites of human cell cultures. J Cell Biol (1989) 1.72
Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice. Proc Natl Acad Sci U S A (1993) 1.68
Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol (1981) 1.58
A cohort study of stomach cancer risk in men after gastric surgery for benign disease. J Natl Cancer Inst (1993) 1.55
Ataxia and abnormal cerebellar microorganization in mice with ablated contactin gene expression. Neuron (1999) 1.52
Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J Invest Dermatol (2000) 1.51
Increased deposition of fibulin-2 in solar elastosis and its colocalization with elastic fibres. Br J Dermatol (2001) 1.51
Systemic scleroderma. Multicenter trial of 1 year of treatment with recombinant interferon gamma. Arch Dermatol (1997) 1.49
Fibroblasts in mechanically stressed collagen lattices assume a "synthetic" phenotype. J Biol Chem (2001) 1.49
Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition. Proc Natl Acad Sci U S A (1997) 1.47
Involvement of the 5'-leader sequence in coupling the stability of a human H3 histone mRNA with DNA replication. Proc Natl Acad Sci U S A (1986) 1.47
Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression. Br J Cancer (2002) 1.45
Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxford) (2009) 1.44
Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop. J Immunol (2000) 1.43
In situ localization of IgG in epidermolysis bullosa acquisita by immunogold technique. J Am Acad Dermatol (1992) 1.40
Selective induction of human heat shock gene transcription by the adenovirus E1A gene products, including the 12S E1A product. Mol Cell Biol (1987) 1.40
Generation of infectious retrovirus aerosol through medical laser irradiation. Lasers Surg Med (1998) 1.39
Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest (1990) 1.36
Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization. Eur J Clin Invest (1988) 1.35
Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in organotypic skin culture. Exp Cell Res (1998) 1.33
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) (2008) 1.32
Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum (2004) 1.29
Comparison of dose calculation algorithms in phantoms with lung equivalent heterogeneities under conditions of lateral electronic disequilibrium. Med Phys (2004) 1.28
Pathogenesis of fibrosis: type 1 collagen and the skin. J Mol Med (Berl) (1998) 1.28
Leukoencephalopathy with ataxia, hypodontia, and hypomyelination. Neurology (2005) 1.26
Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix. Nat Genet (1997) 1.25
Regulation of collagen synthesis in fibroblasts within a three-dimensional collagen gel. Exp Cell Res (1988) 1.24
Binding to human jejunum of serum IgA antibody from children with coeliac disease. Lancet (1990) 1.22
Integrins of normal human epidermis: differential expression, synthesis and molecular structure. Br J Dermatol (1990) 1.20
Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol (2000) 1.19
Recombinant expression and properties of the human calcium-binding extracellular matrix protein BM-40. Eur J Biochem (1991) 1.19
Dermal architecture and collagen type distribution. Arch Dermatol Res (1977) 1.19
Mapping of nidogen binding sites for collagen type IV, heparan sulfate proteoglycan, and zinc. J Biol Chem (1993) 1.18
UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res (1991) 1.17
The absence of nidogen 1 does not affect murine basement membrane formation. Mol Cell Biol (2000) 1.17
Type III procollagen is the major collageneous component produced by a continuous rhabdomyosarcoma cell line. FEBS Lett (1979) 1.16
Base sequence complexity of the stable RNA species of Drosophila melanogaster. Biochemistry (1976) 1.15
Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum (1990) 1.14
Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines. J Biol Chem (1999) 1.13
Localization of collagen alpha 1(I) gene expression during wound healing by in situ hybridization. J Invest Dermatol (1989) 1.12
Extracellular matrix components synthesized by human amniotic epithelial cells in culture. Cell (1980) 1.12
Disorder of collagen metabolism in a patient with osteogenesis imperfecta (lethal type): increased degree of hydroxylation of lysine in collagen types I and III. Eur J Clin Invest (1981) 1.11
Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa. Int J Cancer (2000) 1.11
Normal human primary fibroblasts undergo apoptosis in three-dimensional contractile collagen gels. J Invest Dermatol (1998) 1.09
Expanding the keratin mutation database: novel and recurrent mutations and genotype-phenotype correlations in 28 patients with epidermolytic ichthyosis. Br J Dermatol (2011) 1.07
UVA-induced autocrine stimulation of fibroblast-derived collagenase/MMP-1 by interrelated loops of interleukin-1 and interleukin-6. Photochem Photobiol (1994) 1.07
Fibroblast-matrix interactions in wound healing and fibrosis. Matrix Biol (2000) 1.06
Collagen biosynthesis in systemic scleroderma: regulation of posttranslational modifications and synthesis of procollagen in cultured fibroblasts. J Invest Dermatol (1985) 1.06
Particle-mediated gene transfer of PDGF isoforms promotes wound repair. J Invest Dermatol (1999) 1.05
Downregulation of collagen synthesis in fibroblasts within three-dimensional collagen lattices involves transcriptional and posttranscriptional mechanisms. FEBS Lett (1993) 1.03
Guthrie spots for DNA-based carrier testing in cystic fibrosis. Lancet (1988) 1.03
Effect of overexpression of the small heat shock protein HSP27 on the heat and drug sensitivities of human testis tumor cells. Cancer Res (1996) 1.03
Interleukin 4 and prolonged hypoxia induce a higher gene expression of lysyl hydroxylase 2 and an altered cross-link pattern: important pathogenetic steps in early and late stage of systemic scleroderma? Matrix Biol (2005) 1.03
The marfan's syndrome. In vitro study of collagen metabolism in tissue specimens of the aorta. Exp Cell Biol (1977) 1.02
Osteogenesis imperfecta: biochemical and clinical evaluation of 13 cases. Klin Wochenschr (1981) 1.02
Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy. Neuroscience (2008) 1.02
Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors. Br J Dermatol (2009) 1.01
Aminoterminal extension peptides from type I procollagen normalize excessive collagen synthesis of scleroderma fibroblasts. Arch Dermatol Res (1978) 1.01
Immunofluorescent localization of type IV collagen and laminin in human skin and its application in junctional zone pathology. Br J Dermatol (1982) 1.01
Caffeine hypersensitivity. Allergy (2002) 1.01
Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register. Rheumatology (Oxford) (2009) 1.01
Letters: Fibroblasts from a patient with scleroderma reveal abnormal metabolism. Arch Dermatol Res (1977) 1.01
Expression of intercellular adhesion molecule-1 (ICAM-1) in the skin of patients with systemic scleroderma. J Invest Dermatol (1991) 1.00
Synthesis of collagen by human fibroblasts and their SV40 transformants. Exp Cell Res (1980) 1.00
Ultrastructural binding sites of endomysium antibodies from sera of patients with dermatitis herpetiformis and coeliac disease. Gut (1992) 1.00
Collagenase gene expression in fibroblasts is regulated by a three-dimensional contact with collagen. FEBS Lett (1989) 1.00
Type III collagen aminopropeptide levels in serum of patients with progressive systemic scleroderma. J Invest Dermatol (1986) 1.00
Expression of TGF-beta 1, -beta 2 and -beta 3 in localized and systemic scleroderma. J Dermatol Sci (1999) 0.99
Down-regulation of alpha 3(VI) chain expression by gamma-interferon decreases synthesis and deposition of collagen type VI. Eur J Biochem (1989) 0.99
Limitations of a pencil beam approach to photon dose calculations in lung tissue. Phys Med Biol (1995) 0.98
Influence of corticosteroids on chemotactic response and collagen metabolism of human skin fibroblasts. Biochem Pharmacol (1988) 0.98
Inhibition of fibroblast chemotaxis by superoxide dismutase. Eur J Cell Biol (1987) 0.98
Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus. Br J Dermatol (2005) 0.98
Regulation of collagen VI expression in fibroblasts. Effects of cell density, cell-matrix interactions, and chemical transformation. J Biol Chem (1989) 0.97
Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma. Biochem J (1996) 0.97
Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1. Biochem Biophys Res Commun (2001) 0.96
Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis. J Dermatol Sci (2001) 0.96
Changes in calcium and collagen IV binding caused by mutations in the EF hand and other domains of extracellular matrix protein BM-40 (SPARC, osteonectin). J Mol Biol (1994) 0.96
Fibromatosis hyalinica multiplex (juvenile hyalin fibromatosis). Light microscopic, electron microscopic, immunohistochemical, and biochemical findings. Cancer (1985) 0.96
Up-regulation of keratin 17 expression in human HaCaT keratinocytes by interferon-gamma. J Invest Dermatol (1995) 0.96
Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites. Transplant Proc (1998) 0.96
Stimulation of chemiluminescence in bovine polymorphonuclear leucocytes by virus-antibody complexes and by antibody-coated infected cells. Immunobiology (1983) 0.95
Collagen type distribution and macromolecular organization of connective tissue in different layers of human skin. J Invest Dermatol (1984) 0.95